he purpose of this report was to update the 2006 International League Against Epilepsy (ILAE) report and identify the level of evidence for long-term efficacy or effectiveness for antiepileptic drugs (AEDs) as initial monotherapy for patients with newly diagnosed or untreated epilepsy. All applicable articles from July 2005 until March 2012 were identified, evaluated, and combined with the previous ysis (Glauser et al., 2006) to provide a comprehensive update.
The prior ysis methodology was utilized with three modifications: (1) the detectable noninferiority boundary approach was dropped and both failed superiority studies and prespecified noninferiority studies were yzed using a noninferiority approach, (2) the definition of an adequate comparator was clarified and now includes an absolute minimum point estimate for efficacy/effectiveness, and (3) the relationship table between clinical trial ratings, level of evidence, and conclusions no longer includes a recommendation column to reinforce that this review of efficacy/evidence for specific seizure types does not imply treatment recommendations.
This evidence review contains one clarification: The commission has determined that class I superiority studies can be designed to detect up to a 20% absolute (rather than relative) difference in the point estimate of efficacy/effectiveness between study treatment and comparator using an intent-to-treat ysis. Since July, 2005, three class I randomized controlled trials (RCT) and 11 class III RCTs he been published. The combined ysis (1940-2012) now includes a total of 64 RCTs (7 with class I evidence, 2 with class II evidence) and 11 meta-yses.
New efficacy/effectiveness findings include the following: levetiracetam and zonisamide he level A evidence in s with partial onset seizures and both ethosuximide and valproic acid he level A evidence in children with childhood absence epilepsy.
There are no major changes in the level of evidence for any other subgroup. Levetiracetam and zonisamide join carbamazepine and phenytoin with level A efficacy/effectiveness evidence as initial monotherapy for s with partial onset seizures. Although ethosuximide and valproic acid now he level A efficacy/effectiveness evidence as initial monotherapy for children with absence seizures, there continues to be an alarming lack of well designed, properly conducted epilepsy RCTs for patients with generalized seizures/epilepsies and in children in general.
These findings reinforce the need for multicenter, multinational efforts to design, conduct, and yze future clinically relevant adequately designed RCTs. When selecting a patient's AED, all relevant variables and not just efficacy and effectiveness should be considered.
察看信源地址
上一页:膀胱镜主要能发现什么,有危险吗?
下一页:女性癫痫,这些原因你有关注吗?
- 2022-04-27羊角风的病人应该怎么治疗才只用
- 2022-04-21女性癫痫,这些原因你有关注吗?
- 2022-04-202013年该协会抗癫痫联合会抗癫痫药使用指南
- 2022-02-28明确的癫痫病病因有哪些
- 诺华银屑病药物 Secukinumab 比依那西普好
- 怀孕期间总是感到疼痛。发生了什么事?看完这篇文章,我相信你会明白的。
- 月经周期计算 女性如何计算自己的周期?
- 最新研究 | 转移性乳腺癌一线化疗预后监测新突破
- 第二届微创、超声介入学科发展及临床应用研讨会
- 体检前注意4个禁忌(3)
- 产后胀痛是怎么回事?新妈妈学6招可以预防
- 甲硝唑 VS 替硝唑,只是一字之差吗?
- 今夜就出发,致敬这群“逆行者”!
- 小妹妹一股异味怎么了?
- JCC:炎性肠病患者的间质和肉芽肿性肺病的发病率
- 精囊结石应该做哪些检查
- 专注于小核酸药物的佑嘉生物完成A几千万元融资,渤溢基金领投,凯成资本担任首席财务顾问
- 烧口综合征注意事项!
- 仙鹤草的功效是什么?
- 【健康科普】溢液不容忽视,发现溢液应该这样做
- 彭:疾病常见问题
- 儿童马蹄肾应注意泌尿或其他系统畸形
- 贝安:卵泡多一定是多囊卵巢吗?
- 叉烧包的馅怎么做 很好吃
- 福州一医院用嫩模照片宣传妇科被判赔偿3.2 万
- JAAD:介绍滤泡性湿疹
- 首例新冠肺炎患者长期勃起异常
- 鸽子汤的功效和作用 难怪大多数人术后都喝
- 大多数医生在术前准备穿刺活检时都犯了错误
- 什么病可能是反复低烧?
- 治愈儿童癫痫病都是需要多少费用
- 为什么男同性恋癫痫病难以治愈
- 迈瑞、瑞普等大企业重点布局,新瑞鹏融资额领跑,宠物诊疗迎来爆发丨2020年度盘点
- 如何能帮助癫痫病人更好融为一体社会
- 诊断如何诊断是否患有轻度癫痫
- 癫痫病早期腹泻有哪些
- 明确的癫痫病病因有哪些
- 癫痫定位新方法:无基本立体定向脑电图技术
- 癫痫病治疗花费大概多少钱
- 原发癫痫病能医治吗
- 不注意这些问题,吃多少药都于是就!
- 失眠只是睡很好而已吗?
- 治疗癫痫病本品要怎么治疗好啊
- 癫痫的呕吐是什么